Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan recognition protein S (PGRP-S) is a soluble pattern recognition receptor of the innate immune system that binds bacterial peptidoglycans, a major component of bacterial cell walls, especially from Gram-positive bacteria[1][2][3][4][7]. Highly conserved from insects to mammals, PGRP-S is localized in the granules of human neutrophils and secreted into serum following immune cell activation[2][4]. Upon binding peptidoglycan, PGRP-S can enhance phagocytosis of bacteria by macrophages, increase monocyte/macrophage activation, upregulate surface markers such as CD14, CD80, and CD86, and promote secretion of pro-inflammatory cytokines, contributing to host defense against bacterial infections[2]. It may also protect immune cells from peptidoglycan-induced apoptosis and modulate inflammation[2]. While PGRP-S is not itself bactericidal under some tested conditions, it acts synergistically with other antimicrobial proteins. Structurally, PGRP-S shares overall folding characteristics with other members of the PGRP family and contains binding sites for both peptidoglycan and potentially other host effector molecules[1][3]. No drugs are currently known to directly target PGRP-S, but it is an area of interest as a potential biomarker and modulator for infection and inflammation[2][4][7].
Binds bacterial peptidoglycan, modulates immune cell activity, enhances immune signaling, increases phagocytosis and activation of macrophages
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan recognition protein S (PGRP-S).